ESPEROCT
NDC 0169-8055, antihemophilic factor (recombinant), glycopegylated-exei, kit, from Novo Nordisk.
- Product NDC
- 0169-8055
- Status
- Listed
- Labeler
- Novo Nordisk
- Dosage form
- KIT
- Route
- —
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA125671
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0169-8055 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0169-8055-01 | 00169805501 | 1 KIT in 1 KIT (0169-8055-01) * 4 mL in 1 SYRINGE, GLASS (0169-8008-98) * 4 mL in 1 VIAL, GLASS (0169-8051-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0169-8055 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0169-8055 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0169-8055. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.